---
category: news
title: "Castle Biosciences Completes Acquisition of Cernostics"
excerpt: "Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies. Its TissueCypher® Barrett’s Esophagus Assay is the first precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barrett’s esophagus (BE)."
publishedDateTime: 2021-12-06T12:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211206005078/en/Castle-Biosciences-Completes-Acquisition-of-Cernostics"
webUrl: "https://www.businesswire.com/news/home/20211206005078/en/Castle-Biosciences-Completes-Acquisition-of-Cernostics"
type: article
quality: 4
heat: 4
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "bYcICnAeGupdYRdlmpz7YtbP5J/FV6yOAkNXbY4B/RNTxHvx73CyPeIUXRfxAQ6eGt+gdqjsc0Sxl5x6AgenQkX3/V7YZj5javrh6QVfT/YM8gbmWPGhvpKCBcyroaQEFWsoGy1rJLLjw5uN0XPR44mOfF+MCsjN4K8dhki6kT+NutjVdqxl/lVzBKoU5qyUMepe5X2Tvm9TmywIhwKvma8vDFnGXmhbDYY0nUL5GXHT/8Px2dIP90KKGXXa+qVSybjg8CsvzqJsaBmEfJ2Z0ovwD42TaVvYzZJz0e/CRYrImwDcfmdez5D/ZJzuIGRKuCwDV5jDnq5voiXOdJVlGj8/x/YlH3LAjEQG1P3oVtA=;0S2g25n8R8AhVcgSMAzDKA=="
---

